Amgen Receives FDA Approval For Leukemia Drug Way Ahead Of Schedule By: TalkMarkets December 05, 2014 at 12:00 PM EST Accelerated approval for Blincyto seems to be having mixed effect on AMGN stock. Read More >> Related Stocks: Amgen